Hosted on MSN
Bausch + Lomb outlines Vision '27 strategy while maintaining 2025 revenue guidance at $5.05B–$5.15B
Eye vitamins, PreserVision and Ocuvite grew by 11%, while LUMIFY revenue reached $48 million, up 2%. The consumer dry eye portfolio delivered $113 million in Q3, up 18%, driven by Artelac (up 18%) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback